Psychiatric drugs explained / David Healy ; foreword by Richard Brook
By: Healy, David.
Edinburgh ; New York : Churchill Livingstone Elsevier, 2016Edition: 6h ed.Description: xiv, 339 pages : illustrations ; 24 cm.Content type: text Media type: unmediated Carrier type: volumeISBN: 9780702045080.Subject(s): Psychotropic drugs | Psychopharmacology | Mental illness -- Chemotherapy | Mental Disorders -- drug therapy | Psychotropic Drugs -- therapeutic useGenre/Form: Print books.DDC classification: 615/.788Current location | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|
On Shelf | RM315 .H435 2016 (Browse shelf) | Available | AU0000000005133 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
RM315 .D37 2017 Alcohol, drugs, genes and clinical laboratory : an overview for healthcare and safety professionals / | RM315 .E877 2017 Psychopharmacology / | RM315 .F86 2016 Fundamentals of clinical psychopharmacology / | RM315 .H435 2016 Psychiatric drugs explained / | RM315 .I589 2009 Introduction to neuropsychopharmacology / | RM315 .N47 2020 Nestler, Hyman & Malenkas's molecular neuropharmacology : a foundation for clinical neuroscience / | RM315 .N548 2017 Neuroprotective effects of phytochemicals in neurological disorders / |
Includes bibliographical references and index
Introduction -- Antipsychotics -- Antipsychotic side effects and their management -- Antidepressants -- Side effects of antidepressants -- Management of acute bipolar disorder -- Mood-stabilisers -- Drugs for children -- Anxiety disorders -- Benzodiazepine anxiolytics -- Anxiolysis and the serotonin system -- Beta-blockers and anxiety -- Sleep disorders and insomnia -- Non-pharmacological management of insomnia -- Hypnotics -- Sedatives -- Cognitive enhancement and the dementias -- Cogntive enhancement and neuroprotection -- The range of sexual difficulties -- Effects of drugs on aspects of sexual functioning -- Physical dependence type 1 -- Physical dependence type 2 -- Physical dependence type 3 -- Consent -- Pharmacological abuse -- Liability -- The ethical industry -- Evidence-biased psychiatry -- The marketing of psychiatric disorders -- From health care to Pharmageddon